Inefficient antiviral response in reconstituted small-airway epithelium from chronic obstructive pulmonary disease patients following human parainfluenza virus type 3 infection.
Airway epithelium
Pathogenesis
Respiratory virus
Transcriptome
Journal
Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645
Informations de publication
Date de publication:
02 Apr 2024
02 Apr 2024
Historique:
received:
21
12
2023
accepted:
27
03
2024
medline:
3
4
2024
pubmed:
3
4
2024
entrez:
2
4
2024
Statut:
epublish
Résumé
Chronic obstructive pulmonary disease (COPD) affects over 250 million individuals globally and stands as the third leading cause of mortality. Respiratory viral infections serve as the primary drivers of acute exacerbations, hastening the decline in lung function and worsening the prognosis. Notably, Human Parainfluenza Virus type 3 (HPIV-3) is responsible for COPD exacerbations with a frequency comparable to that of Respiratory Syncytial Virus and Influenza viruses. However, the impact of HPIV-3 on respiratory epithelium within the context of COPD remains uncharacterized.In this study, we employed in vitro reconstitution of lower airway epithelia from lung tissues sourced from healthy donors (n = 4) and COPD patients (n = 5), maintained under air-liquid interface conditions. Through a next-generation sequencing-based transcriptome analysis, we compared the cellular response to HPIV-3 infection.Prior to infection, COPD respiratory epithelia exhibited a pro-inflammatory profile, notably enriched in canonical pathways linked to antiviral response, B cell signaling, IL-17 signaling, and epithelial-mesenchymal transition, in contrast to non-COPD epithelia. Intriguingly, post HPIV-3 infection, only non-COPD epithelia exhibited significant enrichment in interferon signaling, pattern recognition receptors of viruses and bacteria, and other pathways involved in antiviral responses. This deficiency could potentially hinder immune cell recruitment essential for controlling viral infections, thus fostering prolonged viral presence and persistent inflammation.
Identifiants
pubmed: 38566231
doi: 10.1186/s12985-024-02353-7
pii: 10.1186/s12985-024-02353-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
78Informations de copyright
© 2024. The Author(s).
Références
Hewitt R, Farne H, Ritchie A, Luke E, Johnston SL, Mallia P. The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis. 2016;10:158–74.
doi: 10.1177/1753465815618113
pubmed: 26611907
De Serres G, Lampron N, La Forge J, Rouleau I, Bourbeau J, Weiss K, Barret B, Boivin G. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol. 2009;46:129–33.
doi: 10.1016/j.jcv.2009.07.010
pubmed: 19665425
pmcid: 7108387
Bouquet J, Tabor DE, Silver JS, Nair V, Tovchigrechko A, Griffin MP, Esser MT, Sellman BR, Jin H. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort. Respir Res. 2020;21:77.
doi: 10.1186/s12931-020-01340-0
pubmed: 32228581
pmcid: 7104712
Pawełczyk M, Kowalski ML. The role of human parainfluenza virus infections in the immunopathology of the respiratory tract. Curr Allergy Asthma Rep. 2017;17:16.
doi: 10.1007/s11882-017-0685-2
pubmed: 28283855
pmcid: 7089069
Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, Collins PL, Pickles RJ. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol. 2005;79:1113–24.
doi: 10.1128/JVI.79.2.1113-1124.2005
pubmed: 15613339
pmcid: 538579
Russell CD, Unger SA, Walton M, Schwarze J. The human immune response to respiratory syncytial virus infection. Clin Microbiol Rev. 2017;30:481–502.
doi: 10.1128/CMR.00090-16
pubmed: 28179378
pmcid: 5355638
Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30:2114–20.
doi: 10.1093/bioinformatics/btu170
pubmed: 24695404
pmcid: 4103590
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
doi: 10.1093/bioinformatics/bts635
pubmed: 23104886
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
doi: 10.1186/s13059-014-0550-8
pubmed: 25516281
pmcid: 4302049
Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009;135:505–12.
doi: 10.1378/chest.08-0412
pubmed: 19201713
Gohy S, Carlier FM, Fregimilicka C, Detry B, Lecocq M, Ladjemi MZ, Verleden S, Hoton D, Weynand B, Bouzin C, Pilette C. Altered generation of ciliated cells in chronic obstructive pulmonary disease. Sci Rep. 2019;9:17963.
doi: 10.1038/s41598-019-54292-x
pubmed: 31784664
pmcid: 6884487
Roessler FK, Benedikter BJ, Schmeck B, Bar N. Novel computational analysis of large transcriptome datasets identifies sets of genes distinguishing chronic obstructive pulmonary disease from healthy lung samples. Sci Rep. 2021;11:10258.
doi: 10.1038/s41598-021-89762-8
pubmed: 33986404
pmcid: 8119951
Steiling K, van den Berge M, Hijazi K, Florido R, Campbell J, Liu G, Xiao J, Zhang X, Duclos G, Drizik E, Si H, Perdomo C, Dumont C, Coxson HO, Alekseyev YO, Sin D, Pare P, Hogg JC, McWilliams A, Hiemstra PS, Sterk PJ, Timens W, Chang JT, Sebastiani P, O’Connor GT, Bild AH, Postma DS, Lam S, Spira A, Lenburg ME. A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am J Respir Crit Care Med. 2013;187:933–42.
doi: 10.1164/rccm.201208-1449OC
pubmed: 23471465
pmcid: 3707363
Mostafaei S, Kazemnejad A, Azimzadeh Jamalkandi S, Amirhashchi S, Donnelly SC, Armstrong ME, Doroudian M. Identification of novel genes in human airway epithelial cells associated with chronic obstructive Pulmonary Disease (COPD) using machine-based learning algorithms. Sci Rep. 2018;8:15775.
doi: 10.1038/s41598-018-33986-8
pubmed: 30361509
pmcid: 6202402
Camargo L, do N, Righetti RF, de Almeida FM, Dos Santos TM, Fukuzaki S, Martins NAB, Barbeiro MC, Saraiva-Romanholo BM, Lopes FDTQDS, Leick EA, Prado CM. Tibério I De FLC. Modulating asthma-COPD overlap responses with IL-17 inhibition. Front Immunol. 2023;14:1271342.
Mebratu YA, Tesfaigzi Y. IL-17 plays a role in respiratory syncytial virus-induced lung inflammation and emphysema in elastase and LPS-injured mice. Am J Respir Cell Mol Biol. 2018;58:717–26.
doi: 10.1165/rcmb.2017-0265OC
pubmed: 29314865
pmcid: 6002655
Ma R, Su H, Jiao K, Liu J. Association between IL-17 and chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2023;18:1681–90.
doi: 10.2147/COPD.S412626
pubmed: 37551391
pmcid: 10404405
Yang J, Tian B, Sun H, Garofalo RP, Brasier AR. Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition. Nat Microbiol. 2017;2:17086.
doi: 10.1038/nmicrobiol.2017.86
pubmed: 28581456
pmcid: 5501188
Lukashev D, Klebanov B, Kojima H, Grinberg A, Ohta A, Berenfeld L, Wenger RH, Ohta A, Sitkovsky M. Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4 + and CD8 + T lymphocytes. J Immunol. 2006;177:4962–5.
doi: 10.4049/jimmunol.177.8.4962
pubmed: 17015677
Jing Y, Gimenes JA, Mishra R, Pham D, Comstock AT, Yu D, Sajjan U. NOTCH3 contributes to rhinovirus-induced goblet cell hyperplasia in COPD airway epithelial cells. Thorax. 2019;74:18–32.
doi: 10.1136/thoraxjnl-2017-210593
pubmed: 29991510
Garcia GL, Valenzuela A, Manzoni T, Vaughan AE, López CB. Distinct chronic post-viral lung diseases upon infection with influenza or parainfluenza viruses differentially impact superinfection outcome. Am J Pathol. 2020;190:543–53.
doi: 10.1016/j.ajpath.2019.11.003
pubmed: 31866346
pmcid: 7073775
Zhang L, Collins PL, Lamb RA, Pickles RJ. Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus. Virology. 2011;421:67–77.
doi: 10.1016/j.virol.2011.08.020
pubmed: 21986028
Schaap-Nutt A, Liesman R, Bartlett EJ, Scull MA, Collins PL, Pickles RJ, Schmidt AC. Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium. Virology. 2012;433:320–8.
doi: 10.1016/j.virol.2012.08.027
pubmed: 22959894
Kumar RK, Foster PS, Rosenberg HF. Respiratory viral infection, epithelial cytokines, and innate lymphoid cells in asthma exacerbations. J Leukoc Biol. 2014;96:391–6.
doi: 10.1189/jlb.3RI0314-129R
pubmed: 24904000
pmcid: 4138203
Schneider D, Ganesan S, Comstock AT, Meldrum CA, Mahidhara R, Goldsmith AM, Curtis JL, Martinez FJ, Hershenson MB, Sajjan U. Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182:332–40.
doi: 10.1164/rccm.200911-1673OC
pubmed: 20395558
pmcid: 2921598
Veerati PC, Troy NM, Reid AT, Li NF, Nichol KS, Kaur P, Maltby S, Wark PAB, Knight DA, Bosco A, Grainge CL, Bartlett NW. Airway epithelial cell immunity is delayed during rhinovirus infection in asthma and COPD. Front Immunol. 2020;11:974.
doi: 10.3389/fimmu.2020.00974
pubmed: 32499788
pmcid: 7243842